Richard E Whitlow MD PA

Genetesis launched CardioFlux Membership, offering regular heart scans at CardioFlux Imaging Institutes to monitor myocardial fitness via CardioFlux Score. The program coincides with the opening of their first institute in Mason, Ohio, with plans for national expansion. The CardioFlux Score, assessable only via Genetesis' CardioFlux MCG device, analyzes 14 biomarkers of heart muscle electrical activity. Memberships are available in three plans, with results accessible via personalized online accounts. Genetesis aims to prevent heart disease through regular heart health monitoring.